LCN-2 protects against diet-induced NAFLD by regulating lipolysis, fatty acid oxidation, de novo lipogenesis, lipid peroxidation, and apoptosis (Xu et al., 2019). Here, LCN2 is linked to metabolic dysfunction-associated steatotic liver disease.